Nanobacter Sanguinium and Atherosclerosis

Nanobacter Sanguinium and Atherosclerosis

Nanobacter sanguinium and Atherosclerosis

A recent development in understanding the causation of atherosclerosis lies in the area of microbiology. The presence of
genetic material from the bacterium Nanobacter sanquinium has been found in a
disproportionate number of people with atherosclerosis (as well as arthritis). This has led to the opinion among basic researchers that Nanobacter
sanquinium
plays a significant role in many
cases of plaque formation, thus in strokes and heart attacks. Nanobacter
sanquinium
is believed to have the ability to colonize the intima of blood vessels (and
apparently joints as well) and build a calcium matrix around itself. It is then
protected from the immune system as well as from any antibiotics which might be administered.
The solution which has been devised is EDTA in combination with Tetracycline.
The EDTA decalcifies the Nanobacter sanquinium and Tetracycline kills
it.

This risk factor is not yet commonly tested for and if the past performance of standardized medicine is any indication
(consider the role of Heliobactor pylori in the causation of peptic ulcers), it will be about 2012 before it becomes routine. If
you want to be tested now, in all but the best doctors’ offices, you will have to ask for it and bring in the research to back up
your request.

Comments are closed.